178 related articles for article (PubMed ID: 30849340)
1. Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin.
Seliger JM; Martin HJ; Maser E; Hintzpeter J
Chem Biol Interact; 2019 May; 305():156-162. PubMed ID: 30849340
[TBL] [Abstract][Full Text] [Related]
2. The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10.
Seliger JM; Misuri L; Maser E; Hintzpeter J
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):607-614. PubMed ID: 29532688
[TBL] [Abstract][Full Text] [Related]
3. Disposition of hop prenylflavonoids in human breast tissue.
Bolca S; Li J; Nikolic D; Roche N; Blondeel P; Possemiers S; De Keukeleire D; Bracke M; Heyerick A; van Breemen RB; Depypere H
Mol Nutr Food Res; 2010 Jul; 54 Suppl 2(0 2):S284-94. PubMed ID: 20486208
[TBL] [Abstract][Full Text] [Related]
4. Hop-derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein (BCRP/ABCG2).
Tan KW; Cooney J; Jensen D; Li Y; Paxton JW; Birch NP; Scheepens A
Mol Nutr Food Res; 2014 Nov; 58(11):2099-110. PubMed ID: 25044854
[TBL] [Abstract][Full Text] [Related]
5. Interaction of prenylated chalcones and flavanones from common hop with phosphatidylcholine model membranes.
Wesołowska O; Gąsiorowska J; Petrus J; Czarnik-Matusewicz B; Michalak K
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):173-84. PubMed ID: 24060562
[TBL] [Abstract][Full Text] [Related]
6. Reductive Metabolism of Xanthohumol and 8-Prenylnaringenin by the Intestinal Bacterium Eubacterium ramulus.
Paraiso IL; Plagmann LS; Yang L; Zielke R; Gombart AF; Maier CS; Sikora AE; Blakemore PR; Stevens JF
Mol Nutr Food Res; 2019 Jan; 63(2):e1800923. PubMed ID: 30471194
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes.
Nikolic D; Li Y; Chadwick LR; Pauli GF; van Breemen RB
J Mass Spectrom; 2005 Mar; 40(3):289-99. PubMed ID: 15712367
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218.
Ferguson DC; Cheng Q; Blanco JG
Drug Metab Dispos; 2015 Jul; 43(7):922-7. PubMed ID: 25918240
[TBL] [Abstract][Full Text] [Related]
9. Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs.
Hara A; Endo S; Matsunaga T; El-Kabbani O; Miura T; Nishinaka T; Terada T
Biochem Pharmacol; 2017 Aug; 138():185-192. PubMed ID: 28450226
[TBL] [Abstract][Full Text] [Related]
10. Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2).
Peluso MR; Miranda CL; Hobbs DJ; Proteau RR; Stevens JF
Planta Med; 2010 Oct; 76(14):1536-43. PubMed ID: 20309792
[TBL] [Abstract][Full Text] [Related]
11. Conformational modulation of the farnesoid X receptor by prenylflavonoids: Insights from hydrogen deuterium exchange mass spectrometry (HDX-MS), fluorescence titration and molecular docking studies.
Yang L; Broderick D; Campbell Y; Gombart AF; Stevens JF; Jiang Y; Hsu VL; Bisson WH; Maier CS
Biochim Biophys Acta; 2016 Dec; 1864(12):1667-1677. PubMed ID: 27596062
[TBL] [Abstract][Full Text] [Related]
12. Quantification of xanthohumol, isoxanthohumol, 8-prenylnaringenin, and 6-prenylnaringenin in hop extracts and derived capsules using secondary standards.
Dhooghe L; Naessens T; Heyerick A; De Keukeleire D; Vlietinck AJ; Pieters L; Apers S
Talanta; 2010 Dec; 83(2):448-56. PubMed ID: 21111159
[TBL] [Abstract][Full Text] [Related]
13. Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats.
Hanske L; Loh G; Sczesny S; Blaut M; Braune A
Mol Nutr Food Res; 2010 Oct; 54(10):1405-13. PubMed ID: 20397197
[TBL] [Abstract][Full Text] [Related]
14. S-nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity.
Hartmanová T; Tambor V; Lenčo J; Staab-Weijnitz CA; Maser E; Wsól V
Chem Biol Interact; 2013 Feb; 202(1-3):136-45. PubMed ID: 23295225
[TBL] [Abstract][Full Text] [Related]
15. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin.
Bains OS; Karkling MJ; Grigliatti TA; Reid RE; Riggs KW
Drug Metab Dispos; 2009 May; 37(5):1107-14. PubMed ID: 19204081
[TBL] [Abstract][Full Text] [Related]
16. Understanding the binding of daunorubicin and doxorubicin to NADPH-dependent cytosolic reductases by computational methods.
Pirolli D; Giardina B; Mordente A; Ficarra S; De Rosa MC
Eur J Med Chem; 2012 Oct; 56():145-54. PubMed ID: 22982121
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus.
Henderson MC; Miranda CL; Stevens JF; Deinzer ML; Buhler DR
Xenobiotica; 2000 Mar; 30(3):235-51. PubMed ID: 10752639
[TBL] [Abstract][Full Text] [Related]
18. Flavonoids as inhibitors of human carbonyl reductase 1.
Carlquist M; Frejd T; Gorwa-Grauslund MF
Chem Biol Interact; 2008 Jul; 174(2):98-108. PubMed ID: 18579125
[TBL] [Abstract][Full Text] [Related]
19. The modulation of carbonyl reductase 1 by polyphenols.
Boušová I; Skálová L; Souček P; Matoušková P
Drug Metab Rev; 2015; 47(4):520-33. PubMed ID: 26415702
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of flavonoids as potent inhibitors of carbonyl reductase 1 (CBR1).
Arai Y; Endo S; Miyagi N; Abe N; Miura T; Nishinaka T; Terada T; Oyama M; Goda H; El-Kabbani O; Hara A; Matsunaga T; Ikari A
Fitoterapia; 2015 Mar; 101():51-6. PubMed ID: 25549925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
